18F-Fluciclovine PET/CT in Multiple Myeloma

NCT06103838 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

NIH

Sponsor class

Conditions

Multiple Myeloma
Newly Diagnosed Multiple Myeloma (NDMM)
Relapsed and/or Refractory Multiple Myeloma (RRMM)

Interventions

DRUG: 18F-fluciclovine injection
PROCEDURE: 18F-FDG PET/CT

Sponsor

National Cancer Institute (NCI)